Development of Novel Mesoporous Silica-Based Bioactive Glass Scaffolds with Drug Delivery Capabilities


Article Preview

Novel silica-based bioactive glasses were successfully prepared by the sol-gel method. The optimized glass composition for fabrication of the scaffolds was (in mol.%) 60% SiO2 – 30% CaO - 5% Na2O - 5% P2O5 (60S30C5N5P). This composition was confirmed to develop a thick hydroxycarbonate apatite (HCA) layer in Simulated Body Fluid (SBF) after 7 days, as revealed by Fourier Transform Infrared Spectroscopy (FTIR), indicating the bioactive character of the scaffolds. The mesoporous nature of the glass structure allows the load of tetracycline and a sustained release of the drug in PBS during 7 days was measured.



Edited by:

Pietro Vincenzini




A. Philippart et al., "Development of Novel Mesoporous Silica-Based Bioactive Glass Scaffolds with Drug Delivery Capabilities", Advances in Science and Technology, Vol. 96, pp. 54-60, 2014

Online since:

October 2014




* - Corresponding Author

[1] Hoppe, A.; Güldal, N.S.; Boccaccini, A.R. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011, 32, 2757-2774.


[2] Vallet-Regí, M.; Izquierdo-Barba, I.; Colilla, M. Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences 2012, 370, 1400–21.


[3] Yan, X.; Yu, C.; Zhou, X.; Tang, J.; Zhao, D. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angewandte Chemie (International ed. in English) 2004, 43, 5980–4.


[4] Li, X.; Wang, X.; Chen, H.; Jiang, P.; Dong, X.; Shi, J. Hierarchically Porous Bioactive Glass Scaffolds Synthesized with a PUF and P123 Co-templated Approach. Chem. Mat. 2007, 19, 4322–4326.


[5] Zhu, Y.; Wu, C.; Ramaswamy, Y.; Kockrick, E.; Simon, P.; Kaskel, S.; Zreiqat, H. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Microporous and Mesoporous Materials 2008, 112, 494–503.


[6] Wu, C.; Chang, J. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application. Interface Focus 2012, 2, 292–306.


[7] Chen, Q.Z.; Li, Y.; Jin, L.Y.; Quinn, J.M.W.; Komesaroff, P.A. A new sol–gel process for producing Na2O-containing bioactive glass ceramics. Acta Biomaterialia 2010, 6, 4143–4153.


[8] Chen, Q. Z.; Thompson, I. D.; Boccaccini, A. R., 45S5 Bioglass®-derived glass–ceramic scaffolds for bone tissue engineering. Biomaterials 2006 , 27, 2414-2425.


[9] Wu, C.; Chang, J. Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug/growth factors. J. Control. Release 2014, http: /dx. doi. org/10. 1016/j. jconrel. 2014. 04. 026.

[10] Domingues, Z.R.; Cortés, M.E.; Gomes, T.A.; Diniz, H. F et al. Bioactive glass as a drug delivery system of tetracycline associated with β-cyclodextrin. Biomaterials 2004, 25, 327-333.


[11] Pereira, M.M.; Clark, A.E.; Hench, L.L. Calcium phosphate formation on sol-gel-derived bioactive glasses in vitro. J. Biomed. Mater. Res. 1994, 28, 693-698.


[12] Farmer, V. In Infrared spectra of minerals in Mineralogical, Society Monograph 4; Farmer, V., Ed.; London, 1974; p.183–204.

[13] Smith, B. Infrared Spectral Interpretation: a systematic approach; CRC press: New York, 1999; p.169.

[14] Ibrahim, D. M.; Hegazy, W. H.; Mahgoub, A. E.; Abo-Elmajed, H. Commun. Fac. Sci. Univ. Ank. Series B 2000, 46, 33–46.

[15] Stanciu, G. A.; Sandulescu, I.; Savu, B.; Stanciu, S. G.; Paraskevopoulos, K. M.; Chatzistavrou, X.; Koidis, P. Journal of Biomedical and Pharmaceutical Engineering 2007, 1, 34–39.